EP4147050A1 - Procédé pour la détection de corona virus - Google Patents

Procédé pour la détection de corona virus

Info

Publication number
EP4147050A1
EP4147050A1 EP21724288.2A EP21724288A EP4147050A1 EP 4147050 A1 EP4147050 A1 EP 4147050A1 EP 21724288 A EP21724288 A EP 21724288A EP 4147050 A1 EP4147050 A1 EP 4147050A1
Authority
EP
European Patent Office
Prior art keywords
coronavirus
binding agent
cov
antigen
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21724288.2A
Other languages
German (de)
English (en)
Inventor
David John LUNN
Mona Kab OMIR
Alex SHEPPARD
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vatic Health Ltd
Original Assignee
Senseutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senseutics Ltd filed Critical Senseutics Ltd
Publication of EP4147050A1 publication Critical patent/EP4147050A1/fr
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/165—Coronaviridae, e.g. avian infectious bronchitis virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des procédés nouveaux et améliorés pour la détection d'agents pathogènes, par exemple des pathogènes viraux, dans des échantillons. Les procédés, les tests et les dosages permettant l'identification d'une infection, par exemple une infection par le Coronavirus, dans un échantillon, mais peuvent également être utilisés en tant que moyen pour identifier l'état infectieux ou le "degré d'infectivité" d'un sujet. L'invention concerne un procédé de détection d'un antigène dans un échantillon, ledit procédé comprenant: la mise en contact de l'échantillon avec un agent de liaison à l'antigène, l'agent de liaison à l'antigène n'étant pas un anticorps.
EP21724288.2A 2020-05-07 2021-05-07 Procédé pour la détection de corona virus Pending EP4147050A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB2006815.1A GB202006815D0 (en) 2020-05-07 2020-05-07 Method
PCT/EP2021/062222 WO2021224493A1 (fr) 2020-05-07 2021-05-07 Procédé pour la détection de corona virus

Publications (1)

Publication Number Publication Date
EP4147050A1 true EP4147050A1 (fr) 2023-03-15

Family

ID=71134859

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21724288.2A Pending EP4147050A1 (fr) 2020-05-07 2021-05-07 Procédé pour la détection de corona virus

Country Status (3)

Country Link
EP (1) EP4147050A1 (fr)
GB (1) GB202006815D0 (fr)
WO (1) WO2021224493A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111879933B (zh) * 2020-07-30 2023-10-03 广州德成生物科技有限公司 检测新型冠状病毒的免疫层析试纸
EP4220166A1 (fr) * 2022-02-01 2023-08-02 Universitat Rovira I Virgili (URV) Procédé de détection in vitro d'anticorps dans un échantillon

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR102021003012A2 (pt) * 2020-02-19 2021-11-30 Univ Berlin Charite Métodos para o diagnóstico de infecção por sars-cov-2, kit e usos
ES2788459T1 (es) * 2020-02-20 2020-10-21 Euroimmun Medizinische Labordiagnostika Ag Método y reactivos para el diagnóstico de SARS-CoV-2
CN111351941A (zh) * 2020-02-21 2020-06-30 南京岚煜生物科技有限公司 一种新型冠状病毒IgM检测试剂、试剂卡、试剂盒及其制备方法
CN111398581B (zh) * 2020-02-27 2021-05-25 四川省医学科学院·四川省人民医院 一种covid-19快速诊断试剂盒及其制备方法
CN111024954A (zh) * 2020-03-09 2020-04-17 深圳市易瑞生物技术股份有限公司 联合检测covid-19抗原和抗体的胶体金免疫层析装置及其使用法
CN111273006A (zh) * 2020-03-10 2020-06-12 四川沃文特生物技术有限公司 一种新型冠状病毒SARS-CoV-2 S蛋白检测方法

Also Published As

Publication number Publication date
GB202006815D0 (en) 2020-06-24
WO2021224493A1 (fr) 2021-11-11

Similar Documents

Publication Publication Date Title
Cavalera et al. A multi-target lateral flow immunoassay enabling the specific and sensitive detection of total antibodies to SARS COV-2
JP7260192B2 (ja) マイコプラズマ・ニューモニエの免疫学的検出法およびキット
CN111562369A (zh) SARS-CoV-2中和抗体检测试剂盒
US20230204574A1 (en) Rapid, point of care detection of neutralizing antibodies against a virus
US20210325388A1 (en) Lateral flow detection device for detecting a coronavirus by immunoassay
CN111912980A (zh) 唾液中新型冠状病毒抗原和抗体的快速联合检测装置及其制备方法
US20220074938A1 (en) Method of detecting pathogens and/or antigens in samples
CN111999507B (zh) 一种检测新型冠状病毒抗体的荧光免疫层析试纸
EP4147050A1 (fr) Procédé pour la détection de corona virus
CN113295865B (zh) 检测SARS-CoV-2病毒中和抗体的免疫层析装置及其应用
US11255855B1 (en) COVID-19 spike-ACE2 binding assay for drug and antibody screening
KR20210133846A (ko) 사스 코로나바이러스 2 스파이크 단백질과 결합하는 수용체와 항체를 포함하는 사스 코로나바이러스 2 진단 키트
CN111796093A (zh) 一种新型冠状病毒、mers与甲/乙型流感病毒四合一快速检测试剂盒
US20230194529A1 (en) Rapid Assay Methods and Kits for Detecting Neutralizing Antibody for Sars-Cov-2 Using Lateral Flow Assay and Enzyme-linked Immunosorbent Assay
US20210247395A1 (en) Antibody pairs for use in a rapid influenza b diagnostic test
WO2023112859A1 (fr) Bâtonnet diagnostique d'immunochromatographie et kit d'immunochromatographie, procédé d'immuno-essai l'utilisant et procédé de filtration d'échantillon
WO2006043614A1 (fr) Procédé d’immunoanalyse de membrane
WO2023017817A1 (fr) Procédé de dosage immunologique, diluant d'échantillon et kit d'immunochromatographie
CN112334478A (zh) 用于快速甲型流感诊断测试的抗体对
US20210373018A1 (en) Lateral flow detection device for detecting a coronavirus by immunoassay
CN113391075B (zh) 一种新型冠状病毒中和抗体检测试纸条和试剂盒
WO2020188602A1 (fr) Procédé basé sur des protéines immunodominante pour différencier les animaux infectés par la brucellose des animaux vaccinés
JP2022023357A (ja) シグナルの低下を改善した検査試薬
JP7226878B1 (ja) 検査方法、イムノクロマトグラフィーテストストリップ、及びイムノクロマトグラフィーキット
EP3904877A1 (fr) Dispositif de détection sur membrane pour détecter un coronavirus par dosage immunologique

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20221207

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)